Skip to main content

Sickle Cell Pulmonary Clinic

US News & World Report Honor Roll Badge

Children's National has one of the largest and most active pediatric sickle cell programs in the country. Many sickle cell patients have associated, unrecognized lung disease, and the Sickle Cell Pulmonary Clinic is dedicated exclusively for children and adolescents with sickle cell disease who require specialized pulmonary care.

Our Providers

Our pediatric specialists provide personalized care for your child’s physical, mental and emotional health needs.

Contact Information

For appointments, please call 1-888-884-BEAR (2327) and for information, call 202-476-2128.

Improving Patient Outcomes

Our goal is to moderate complications associated with the disease and help improve quality of life for patients — enable our young patients to enjoy a normal childhood as much as possible.

Our pulmonary physicians have the experience and expertise to accurately diagnose any pulmonary concerns. They work closely with hematologists to improve the pulmonary health of children with sickle cell disease and increase survival rates for children.

We see patients with referrals from Children’s hematology physicians, and patients referred for evaluation and treatment of acute chest syndrome, asthma, hypoxia, and recurrent pneumonia. Our team works closely with the Pulmonary Diagnostic Laboratory, which performs diagnostic pulmonary function testing with diffusion capacity. These tests measure the effectiveness of oxygen transfer between the lungs and the bloodstream.

Members of the Children’s National Sickle Cell Disease Program team explain the process and importance of blood donation for sickle cell patients and their families.


 Kendric, a 12-year-old boy from the Washington, D.C., area, is the first patient in the world with sickle cell disease to begin a gene therapy that may cure his condition

First Ever Sickle Cell Gene Therapy

On May 6, 2024, at Children's National, 12 year-old Kendric received the world's first gene therapy treatment for sickle cell disease. Approved in December 2023 by the FDA, these treatments are created by collecting and editing the patient's own blood cells and reintroducing them to the body. (The New York Times, account required)

 Kendric, a 12-year-old boy from the Washington, D.C., area, is the first patient in the world with sickle cell disease to begin a gene therapy that may cure his condition

Administrative Contact Information

To contact our administrative team, call 202-476-2478. To send a fax, dial 202-476-5864.

child with watering can

Help Your Child Grow Up Stronger

Read about everything parents need to know about kids' health, straight from our experts at Children's National Hospital.

child with watering can